Safety and Clinical Activity of CAVATAK™ Alone or With Low Dose Mitomycin C in Non-muscle Invasive Bladder Cancer (CANON)

Clinical Trial ID NCT02316171

Rank	Title	Journal	Year	PubWeight™‹?›
1	Trial Watch-Oncolytic viruses and cancer therapy.	Oncoimmunology	2015	0.83
2	Oncolytic virotherapy for urological cancers.	Nat Rev Urol	2016	0.76